Advances in stereotactic body radiation therapy for hepatocellular carcinoma
10.3969/j.issn.1000-8179.2020.08.140
- VernacularTitle: 立体定向放射治疗在肝细胞癌治疗中的应用进展
- Author:
Yongchun SONG
1
Author Information
1. Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer
- Publication Type:Journal Article
- Keywords:
Hepatocellular carcinoma;
Immunotherapy;
Radiotherapy;
Stereotactic body radiation therapy
- From:
Chinese Journal of Clinical Oncology
2020;47(8):427-430
- CountryChina
- Language:Chinese
-
Abstract:
Stereotactic body radiation therapy (SBRT) is a high-precision radiotherapy technology that provides high-dose and high-precision radiotherapy through less fractional irradiation. SBRT can significantly improve local control and survival rates in patients with hepatocellular carcinoma (HCC). SBRT can also be an effective and safe bridging therapy for patients awaiting liver transplantation. Moreover, recent studies have reported the potential effects of the combination of SBRT and immune checkpoint inhibitors. This article reviews the safety and efficacy of SBRT in the treatment of HCC, in anticipation of the future application of SBRT in combination with immunotherapy.
